D-0084-2027 Class I Ongoing

Recalled by Greenwich Rx — Tomball, TX

FDA drug recall D-0084-2027 was initiated by Greenwich Rx on Oct 1, 2026 and is designated Class I. Reason for recall: Microbial Contamination of Sterile Products The recall status is ongoing. Affected quantity: 4,319 vials.

Recall details

Product Type
Drugs
Report Date
Oct 28, 2026
Initiation Date
Oct 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,319 vials

Product description

Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial, Rx only, Subcutaneous Only, Greenwich Rx.

Reason for recall

Microbial Contamination of Sterile Products

Distribution pattern

US Nationwide in th USA

Code information

Lot # 0060-062426-1, BUD: 10/02/2026; Lot # 0060-062726-1, BUD: 10/05/2026; Lot # 0060-070926-1, BUD: 10/17/2026; Lot # 0060-071426-1, BUD: 10/22/2026; Lot #0060-071426-2, BUD: 10/22/2026; Lot # 0060-072026-1, BUD: 10/28/2026; Lot # 0060-072726-1, BUD: 11/04/2026; Lot #0060-072926-1, BUD: 11/06/2026; Lot # 0060-073126-1; BUD: 11/08/2026; Lot # 0060-080426-1, BUD: 11/12/2026; Lot #: 0060-080526-1, BUD: 11/13/2026; Lot # 0060-081826-1, BUD: 11/26/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0084-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0084-2027. Report a data issue: hello@regdatalab.com.